Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to 41.59%.

  • Bio's EBITDA Margin rose 128500.0% to 41.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 50.69%, marking a year-over-year increase of 97800.0%. This contributed to the annual value of 54.61% for FY2024, which is 253300.0% up from last year.
  • According to the latest figures from Q3 2025, Bio's EBITDA Margin is 41.59%, which was up 128500.0% from 49.12% recorded in Q2 2025.
  • Bio's 5-year EBITDA Margin high stood at 34.06% for Q1 2024, and its period low was 123.69% during Q1 2021.
  • In the last 5 years, Bio's EBITDA Margin had a median value of 78.3% in 2024 and averaged 78.19%.
  • As far as peak fluctuations go, Bio's EBITDA Margin skyrocketed by 693600bps in 2021, and later crashed by -267600bps in 2025.
  • Over the past 5 years, Bio's EBITDA Margin (Quarter) stood at 91.4% in 2021, then rose by 11bps to 81.22% in 2022, then increased by 6bps to 76.09% in 2023, then surged by 31bps to 52.51% in 2024, then grew by 21bps to 41.59% in 2025.
  • Its EBITDA Margin was 41.59% in Q3 2025, compared to 49.12% in Q2 2025 and 60.82% in Q1 2025.